Market Research Logo

Morocco Pharmaceuticals & Healthcare Q4 2018

Morocco Pharmaceuticals & Healthcare Q4 2018

Key View:

Pharmaceutical sales in Morocco will be limited by the country's low purchasing power, small pensionable populationand inadequate public health system, dampening demand for high-value chronic disease treatments. Although the government'scommitment to improving healthcare via the expansion of health insurance coverage will be a significant factor for future medicinesales growth, we believe generics drugmakers will be the main beneficiaries as the state adopts a pro-generic stance.


Key View
SWOT
Industry Forecast
Pharmaceutical Market
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
MENA Innovative Pharmaceuticals Risk/Reward Index
Morocco Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
GlaxoSmithKline
Laprophan
Pfizer
Sanofi
Sothema
Morocco Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report